Antiarrhythmic drugs are important for many patients with Eisenmenger syndrome, as evidence suggests that arrhythmia-induced sudden cardiac death may be the leading cause of death among patients with the disease. These therapies generally aim to restore and maintain sinus rhythm, but the specific interventions chosen will depend on the nature of the patient's arrhythmia. Etymology Eisenmenger syndrome was named by Paul Wood after Victor Eisenmenger, who first described the condition in 1897. References External links Heart diseases Health issues in pregnancy Syndromes affecting the heart Syndromes affecting the lung Rare syndromes